Artificial Intelligence (AI) is being adopted across the world and promises a
new revolution in healthcare. While AI-enabled medical devices in North America
dominate 42.3% of the global market, the use of AI-enabled medical devices in
other countries is still a story waiting to be unfolded. We aim to delve deeper
into global regulatory approaches towards AI use in healthcare, with a focus on
how common themes are emerging globally. We compare these themes to the World
Health Organization's (WHO) regulatory considerations and principles on ethical
use of AI for healthcare applications. Our work seeks to take a global
perspective on AI policy by analyzing 14 legal jurisdictions including
countries representative of various regions in the world (North America, South
America, South East Asia, Middle East, Africa, Australia, and the
Asia-Pacific). Our eventual goal is to foster a global conversation on the
ethical use of AI in healthcare and the regulations that will guide it. We
propose solutions to promote international harmonization of AI regulations and
examine the requirements for regulating generative AI, using China and
Singapore as examples of countries with well-developed policies in this area.

人工智能在全球范围内获得采用，并承诺在医疗保健领域引发一场新革命。本研究旨在深入研究全球对于医疗保健中人工智能使用的监管方法，重点关注共同出现的主题并与世界卫生组织的道德使用人工智能原则进行比较。我们分析了包括代表世界各地的 14 个法律辖区在内的国家的 AI 政策，最终目标是促进关于医疗保健中人工智能的道德使用以及指导其发展的监管的全球对话。我们提出解决方案以促进人工智能监管的国际协调，并以中国和新加坡作为在这一领域具有成熟政策的国家进行案例研究。